Literature DB >> 15934484

Modified constraint-induced movement therapy for young children with hemiplegic cerebral palsy: a pilot study.

C E Naylor1, E Bower.   

Abstract

The objective of the study was to evaluate the effectiveness of modified constraint-induced movement therapy in young children with hemiplegia. It was a single-case experimental design using children as their own controls. Assessment was at entry to the study and subsequently at 4-weekly intervals. A 4-week baseline period with no hand treatment, controlling for maturation, was followed by a 4-week treatment period and a second 4-week period with no hand treatment to measure carry-over. Treatment consisted of twice-weekly 1-hour sessions of structured activities with a therapist and a home programme for non-treatment days. Only verbal instruction and gentle restraint of the unaffected arm were used to encourage use of the affected arm. Nine children (six males, three females; median age 31 mo, age range 21 to 61 mo) presenting with congenital spastic hemiplegia (five right side, four left side) were involved in the study. Changes in hand function were evaluated with the Quality of Upper Extremity Skills Test. Improvement was seen throughout the study with statistical significance, using the Wilcoxon signed rank test, of 0.01 immediately after treatment. Results of this pilot study suggest that this modification of constraint-induced movement therapy may be an effective way of treating young children with hemiplegia. Future work is planned to consolidate and develop these results.

Entities:  

Mesh:

Year:  2005        PMID: 15934484     DOI: 10.1017/s0012162205000721

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  9 in total

1.  Effect of botulinum toxin type A and modified constraint-induced movement therapy on motor function of upper limb in children with obstetrical brachial plexus palsy.

Authors:  Andrea Santamato; Francesco Panza; Maurizio Ranieri; Pietro Fiore
Journal:  Childs Nerv Syst       Date:  2011-10-14       Impact factor: 1.475

Review 2.  Cerebral palsy: new approaches to therapy.

Authors:  Marjorie A Garvey; Margot L Giannetti; Katharine E Alter; Peter S Lum
Journal:  Curr Neurol Neurosci Rep       Date:  2007-03       Impact factor: 5.081

3.  Treatment of congenital hemiparesis with pediatric constraint-induced movement therapy.

Authors:  Edward Taub; Angi Griffin; Gitendra Uswatte; Kristin Gammons; Jennifer Nick; Charles R Law
Journal:  J Child Neurol       Date:  2011-07-19       Impact factor: 1.987

4.  Feasibility and effectiveness of home-based therapy programmes for children with cerebral palsy: a systematic review.

Authors:  Laura W M E Beckers; Mellanie M E Geijen; Jos Kleijnen; Eugene A A Rameckers; Marlous L A P Schnackers; Rob J E M Smeets; Yvonne J M Janssen-Potten
Journal:  BMJ Open       Date:  2020-10-06       Impact factor: 2.692

5.  [Congenital hemiplegia. A disease with manifold problems].

Authors:  C Panteliadis; M Tzitiridou; E Pavlidou; C Hagel; A Covanis; G Jacobi
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

6.  Constraint-induced movement therapy in children with unilateral cerebral palsy.

Authors:  Brian J Hoare; Margaret A Wallen; Megan N Thorley; Michelle L Jackman; Leeanne M Carey; Christine Imms
Journal:  Cochrane Database Syst Rev       Date:  2019-04-01

Review 7.  Early intervention evidence for infants with or at risk for cerebral palsy: an overview of systematic reviews.

Authors:  Diane L Damiano; Egmar Longo
Journal:  Dev Med Child Neurol       Date:  2021-04-06       Impact factor: 4.864

8.  Therapies for children with cerebral palsy: A Web of Science-based literature analysis.

Authors:  Yaping Mu; Na Li; Lijun Guan; Chunnan Wang; Shuyun Shang; Yan Wang
Journal:  Neural Regen Res       Date:  2012-11-25       Impact factor: 5.135

9.  INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia.

Authors:  Roslyn Boyd; Leanne Sakzewski; Jenny Ziviani; David F Abbott; Radwa Badawy; Rose Gilmore; Kerry Provan; Jacques-Donald Tournier; Richard A L Macdonell; Graeme D Jackson
Journal:  BMC Neurol       Date:  2010-01-12       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.